in confirmation of previous findings , the binding and degradation of 125i-ldl by human fibroblasts were inhibited approximately 90 % by antibodies 2a or 2b or the antigen-binding fragments of 2a , whereas the cellular processing of 125i-vldl3 ( sf20-60 ) , 125i-vldl2 ( sf60-120 ) , and 125i-vldl1 ( sf greater than 120 ) were inhibited by only approximately 50 % , approximately 25 % , and less than 10 % , respectively .
C0016030
fibroblasts
C0007634
cellular